PatientsVille.com Logo

PatientsVille

Olopatadine Side Effects

Report Olopatadine Side Effects

If you experienced any harmful or unwanted effects of Olopatadine, please share your experience. This could help to raise awareness about Olopatadine side effects, identify uknown risks and inform health professionals and patients taking Olopatadine.

Examples: headache, dizziness


Olopatadine Side Effects reported to FDA

The following Olopatadine reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
The FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Olopatadine on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has identified a causal relationship between the drug and the listed risk.

Page 1 of 2 

Anosmia
on Oct 16, 2012 Female from US , 56 years of age, weighting 140.0 lb, was diagnosed with and was treated with Olopatadine. Directly after, patient experienced the unwanted or unexpected Olopatadine side effects: anosmia. Olopatadine dosage: 2 Spray In Each Postril.

Renal Impairment
Patient was taking Olopatadine Hcl. Patient felt the following Olopatadine side effects: renal impairment on Jun 06, 2012 from JAPAN Additional patient health information: Male , 42 years of age, . Olopatadine Hcl dosage: Unk.
Multiple prescriptions taken:

Blood Potassium Increased, Renal Disorder, Haemoglobin Decreased, Acute Respiratory Failure, Blood Creatinine Increased, Haematocrit Decreased, Blood Alkaline Phosphatase Increased, Blood Urea Increased
Adverse event was reported on May 08, 2012 by a Male taking Olopatadine Hcl (Dosage: N/A) . Location: JAPAN , 78 years of age, After Olopatadine was administered, patient encountered several Olopatadine side effects: blood potassium increased, renal disorder, haemoglobin decreased, acute respiratory failure, blood creatinine increased, haematocrit decreased, blood alkaline phosphatase increased, blood urea increased.
Multiple concurrent drugs taken:
  • Lansoprazole
  • Loxonin
  • Glufast
  • Antebate
  • Prednisolone
  • Prednisolone
  • Zolinza (400 Mg/daily Po, 100 Mg/daily Po, 200 Mg/daily Po)
  • Zolinza (400 Mg/daily Po, 100 Mg/daily Po, 200 Mg/daily Po)


Toxic Skin Eruption
on May 17, 2012 Female from JAPAN , 69 years of age, weighting 88.18 lb, was treated with Olopatadine Hcl. Directly after, patient experienced the unwanted or unexpected Olopatadine side effects: toxic skin eruption. Olopatadine Hcl dosage: N/A.
Associated medications used:


Aggression, Suicide Attempt
on Apr 23, 2012 Female from JAPAN , 39 years of age, was diagnosed with and was treated with Olopatadine Hcl. Patient felt the following Olopatadine side effects: aggression, suicide attempt. Olopatadine Hcl dosage: Unk.
Multiple prescriptions taken:
  • Litiomal
  • Clonazepam
  • Goodmin
  • Yaz (1 Df, Qd)
  • Eticalm


Juvenile Arthritis, Hepatic Function Abnormal
Patient was taking Olopatadine Hcl. After Olopatadine was administered, patient encountered several Olopatadine side effects: juvenile arthritis, hepatic function abnormal on Apr 27, 2012 from JAPAN Additional patient health information: Female , weighting 103.6 lb, was diagnosed with and. Olopatadine Hcl dosage: N/A.
Multiple concurrent drugs taken: Patient was hospitalized.

Haematocrit Increased, Leukocytosis, Chronic Myeloid Leukaemia
Adverse event was reported on Jan 30, 2012 by a Male taking Olopatadine Hcl (Dosage: 10mg Per Day) was diagnosed with and. Location: JAPAN , weighting 211.6 lb, Directly after, patient experienced the unwanted or unexpected Olopatadine side effects: haematocrit increased, leukocytosis, chronic myeloid leukaemia.
Associated medications used:
  • Rabeprazole Sodium (10mg Per Day)
  • Torsemide (8mg Per Day)
  • Lisinopril (10mg Per Day)
  • Ethyl Icosapentate (1800mg Per Day)
  • Allopurinol (100mg Per Day)
  • Flolan


Loss Of Consciousness, Nausea, Vomiting
on Jan 30, 2012 Female from JAPAN , 69 years of age, was treated with Olopatadine Hcl. Patient felt the following Olopatadine side effects: loss of consciousness, nausea, vomiting. Olopatadine Hcl dosage: 10 Mg, 1x/day.
Multiple prescriptions taken:
  • Lyrica (50 Mg, 2x/day)
  • Mucodyne (1000 Mg, 1x/day)
  • Cleanal (400 Mg, 1x/day)
Patient was hospitalized.

Hepatic Neoplasm Malignant, Pyrexia, Neutrophil Count Increased, Hepatic Function Abnormal, Insomnia, Hypertension, Constipation
on Jan 20, 2012 Male from JAPAN , 54 years of age, weighting 138.9 lb, was treated with Olopatadine Hcl. After Olopatadine was administered, patient encountered several Olopatadine side effects: hepatic neoplasm malignant, pyrexia, neutrophil count increased, hepatic function abnormal, insomnia, hypertension, constipation. Olopatadine Hcl dosage: Daily Dose 10 Mg.
Multiple concurrent drugs taken:
  • Atarax (Daily Dose 50 Mg)
  • Nexavar (400 Mg, Qd)
  • Lansoprazole (Daily Dose 15 Mg)
  • Hirudoid (Unk)


Blood Glucose Increased
Patient was taking Olopatadine Hcl. Directly after, patient experienced the unwanted or unexpected Olopatadine side effects: blood glucose increased on Dec 27, 2011 from JAPAN Additional patient health information: Male , 73 years of age, weighting 154.3 lb, . Olopatadine Hcl dosage: N/A.
Associated medications used: Patient was hospitalized.

Blood Albumin Decreased, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Epstein-barr Virus Antibody Positive, Faeces Pale, Allergic Hepatitis, Prothrombin Time Prolonged, Malaise, Prothrombin Time Ratio Decreased
Adverse event was reported on Dec 20, 2011 by a Female taking Olopatadine Hcl (Dosage: N/A) was diagnosed with and. Location: JAPAN , 81 years of age, Patient felt the following Olopatadine side effects: blood albumin decreased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, epstein-barr virus antibody positive, faeces pale, allergic hepatitis, prothrombin time prolonged, malaise, prothrombin time ratio decreased.
Multiple prescriptions taken: Patient was hospitalized.

Laceration
on Dec 13, 2011 Female from JAPAN , 71 years of age, was diagnosed with and was treated with Olopatadine Hcl. After Olopatadine was administered, patient encountered several Olopatadine side effects: laceration. Olopatadine Hcl dosage: 5 Mg, 2x/day.
Multiple concurrent drugs taken:
  • Hirudoid (Unk)
  • Drenison (Unk)
  • Lipitor (10 Mg, Uid/qd)


Pain, Myocardial Infarction, Cerebrovascular Accident, Pulmonary Embolism, Anxiety, Gallbladder Disorder, Deep Vein Thrombosis, Cholecystitis Acute, Cholecystitis Chronic
on Nov 04, 2011 Female from UNITED STATES , 25 years of age, weighting 135.0 lb, was treated with Olopatadine Hydrochloride. Directly after, patient experienced the unwanted or unexpected Olopatadine side effects: pain, myocardial infarction, cerebrovascular accident, pulmonary embolism, anxiety, gallbladder disorder, deep vein thrombosis, cholecystitis acute, cholecystitis chronic. Olopatadine Hydrochloride dosage: Unk Unk, Prn.
Associated medications used:
  • Xanax (Unk)
  • Drospirenone And Ethinyl Estradiol (Unk)
  • Prednisone (Unk)
  • Pepcid (Unk Unk, Qd)
  • Yasmin (Unk)
  • Advair Diskus 100/50 (Unk)
  • Allegra
  • Flonase


Dyspnoea, Burning Sensation
Patient was taking Olopatadine Hydrochloride. Patient felt the following Olopatadine side effects: dyspnoea, burning sensation on Oct 19, 2011 from UNITED STATES Additional patient health information: Male , weighting 195.2 lb, was diagnosed with and. Olopatadine Hydrochloride dosage: N/A.
Multiple prescriptions taken:

Pulmonary Artery Thrombosis, Venous Thrombosis
Adverse event was reported on Oct 12, 2011 by a Female taking Olopatadine Hcl (Dosage: 1 Tablet, As Needed) was diagnosed with
  • pruritus
  • non-small cell lung cancer
  • constipation
and. Location: JAPAN , 29 years of age, weighting 132.3 lb, After Olopatadine was administered, patient encountered several Olopatadine side effects: pulmonary artery thrombosis, venous thrombosis.
Multiple concurrent drugs taken:
  • Crizotinib (250 Mg, 2x/day)
  • Milmag (2 Tablets, As Needed)
  • Kindavate (As Needed)
Patient was hospitalized.

Jaw Disorder, Paralysis, Viith Nerve Paralysis, Apraxia, Tenderness, Cranial Nerve Palsies Multiple, Temporomandibular Joint Syndrome, Dysphagia, Trismus
on Oct 03, 2011 Male from JAPAN , 75 years of age, was treated with Olopatadine Hcl. Directly after, patient experienced the unwanted or unexpected Olopatadine side effects: jaw disorder, paralysis, viith nerve paralysis, apraxia, tenderness, cranial nerve palsies multiple, temporomandibular joint syndrome, dysphagia, trismus. Olopatadine Hcl dosage: N/A.
Associated medications used:
  • Mucosta
  • Cefazolin Sodium (Dosage Form: Powder)
  • Methaderm
  • Ferrum
  • Xyzal
  • Tranexamic Acid
  • Xyzal
  • Bio-three
Patient was hospitalized and became disabled.

Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Hepatic Function Abnormal
on Oct 04, 2011 Male from JAPAN , 71 years of age, weighting 160.9 lb, was treated with Olopatadine Hcl. Patient felt the following Olopatadine side effects: aspartate aminotransferase increased, alanine aminotransferase increased, hepatic function abnormal. Olopatadine Hcl dosage: N/A.
Multiple prescriptions taken:
  • Allopurinol
  • Arava
  • Uralyt
  • Azulfidine
  • Flivas
  • S. Adchnon
  • Comelian
Patient was hospitalized.

White Blood Cell Count Increased, Haematocrit Increased
Patient was taking Olopatadine Hcl. After Olopatadine was administered, patient encountered several Olopatadine side effects: white blood cell count increased, haematocrit increased on Sep 29, 2011 from JAPAN Additional patient health information: Male , weighting 211.6 lb, was diagnosed with
  • rhinitis allergic
  • pulmonary arterial hypertension
  • hyperuricaemia
  • right ventricular failure
  • dyslipidaemia
and. Olopatadine Hcl dosage: 10mg Per Day.
Multiple concurrent drugs taken:
  • Flolan
  • Allopurinol (100mg Per Day)
  • Torsemide (8mg Per Day)
  • Ethyl Icosapentate (1800mg Per Day)
  • Lisinopril (10mg Per Day)
  • Rabeprazole Sodium (10mg Per Day)


Thyroid Cancer
Adverse event was reported on Sep 13, 2011 by a Female taking Olopatadine Hcl (Dosage: N/A) . Location: JAPAN , 37 years of age, weighting 179.0 lb, Directly after, patient experienced the unwanted or unexpected Olopatadine side effects: thyroid cancer.
Associated medications used:
  • Solostar
  • Metformin Hydrochloride (2 Tab Each After Breakfast And Supper)
  • Lantus
  • Lantus
  • Exenatide
  • Metformin Hydrochloride (After Breakfast)
  • Lantus
  • Metformin Hydrochloride (1 Tab Each After Breakfast And Supper)


Dermatitis Bullous
on Aug 15, 2011 Female from JAPAN , 66 years of age, weighting 105.8 lb, was diagnosed with and was treated with Olopatadine Hcl. Patient felt the following Olopatadine side effects: dermatitis bullous. Olopatadine Hcl dosage: N/A.
Multiple prescriptions taken:

Thrombotic Cerebral Infarction, Decreased Appetite
on Jun 20, 2011 Female from JAPAN , 77 years of age, weighting 108.0 lb, was diagnosed with and was treated with Olopatadine Hcl. After Olopatadine was administered, patient encountered several Olopatadine side effects: thrombotic cerebral infarction, decreased appetite. Olopatadine Hcl dosage: 10 Mg, Qd.
Multiple concurrent drugs taken: Patient was hospitalized.

Aspartate Aminotransferase Increased, Hypersensitivity, Alanine Aminotransferase Increased, Eczema Asteatotic, Lymphocyte Count Decreased, Blood Amylase Increased, Rash, Blood Creatinine Increased
Patient was taking Olopatadine. Directly after, patient experienced the unwanted or unexpected Olopatadine side effects: aspartate aminotransferase increased, hypersensitivity, alanine aminotransferase increased, eczema asteatotic, lymphocyte count decreased, blood amylase increased, rash, blood creatinine increased on Jun 14, 2011 from JAPAN Additional patient health information: Male , weighting 121.3 lb, . Olopatadine dosage: N/A.
Associated medications used:
  • Granisetron Hcl
  • Prednisolone
  • Levofloxacin
  • Famotidine
  • Bendamustine Hcl
  • Difluprednate
  • Brotizolam
  • Bendamustine Hcl
Patient was hospitalized.

Hepatitis Acute
Adverse event was reported on Jun 14, 2011 by a Male taking Olopatadine Hcl (Dosage: N/A) . Location: JAPAN , 22 years of age, Patient felt the following Olopatadine side effects: hepatitis acute.
Multiple prescriptions taken: Patient was hospitalized.

Product Formulation Issue, Bone Pain, Asthenia, Viral Infection
on Jul 14, 2010 Male from UNITED STATES , 54 years of age, was treated with Olopatadine. After Olopatadine was administered, patient encountered several Olopatadine side effects: product formulation issue, bone pain, asthenia, viral infection. Olopatadine dosage: N/A.
Multiple concurrent drugs taken:
  • Aspirin
  • Lasix
  • Prolastin-c (5900 Mg, Qw, Iv)
  • Prolastin
  • Albuterol
  • Xanax
  • Advair Diskus 100/50


White Blood Cell Count Increased, Pain Of Skin, Pyrexia, Mobility Decreased, Arthralgia, Hyperuricaemia, C-reactive Protein Increased, Erythrodermic Psoriasis
on Feb 23, 2011 Male from JAPAN , 51 years of age, weighting 187.4 lb, was diagnosed with and was treated with Olopatadine Hydrochloride. Directly after, patient experienced the unwanted or unexpected Olopatadine side effects: white blood cell count increased, pain of skin, pyrexia, mobility decreased, arthralgia, hyperuricaemia, c-reactive protein increased, erythrodermic psoriasis. Olopatadine Hydrochloride dosage: N/A.
Associated medications used:
  • Lansoprazole
  • Enalapril Maleate
  • White Petroleum (Qs)
  • Carvedilol
  • Heparin (Qs)
  • Metenolone
  • Betamethasone Sodium Phosphate (Qs)
  • Ofloxacin (Qs)
Patient was hospitalized.

Page 1 of 2 

Record and Track Your Side Effects

It is very important to keep track of all side effects and discuss them with your doctor. If you think you may have a medical emergency, call your doctor or 911 immediately.

Track Your Side Effects - It's Easy and Free. >> Start Today

Already a User? Log In

Most drugs have a large list of nonsevere or mild adverse effects which do not rule out continued usage. These effects depend on individual sensitivity, and can include nausea, dizziness, diarrhea, malaise, vomiting, headache, dermatitis, dry mouth, etc. Check commonly reported side effects . These can be considered a form of pseudo-allergic reaction, as not all users experience these effects; many users experience none at all.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Tips for Taking Medicines Properly

Before Taking Olopatadine

Find Out How to Take Olopatadine

Discuss Olopatadine Side Effects

Did You Have a Olopatadine Side Effect?

Yes, Severe
Yes, Moderate
Yes, Minor
No

How Effective is Olopatadine for You?

Exceeded Expectations
Effective
Somewhat Effective
Not Effective


JustAnswer.com

Safety Alerts, Active Ingredients, Usage Information

Alternative OLOPATADINE Names:OLOPATADI

Active Ingredient: OLOPATADI

More About Olopatadine

Side Effects reported to FDA: 28

Olopatadine safety alerts: No

Reported deaths: 2

Reported hospitalizations: 13

Latest Olopatadine clinical trials

Related health facts